We are studying the safety and appropriate dose of asciminib in children with chronic myeloid leukemia. This research aims to ensure the medication is safe and effective for young patients who have already tried other treatments.
Health conditions and diseases that the clinical trial is designed to study and treat.
Philadelphia Positive Chronic Myeloid Leukemia (Ph+ CML) is a type of cancer that affects the blood and bone marrow, characterized by the presence of the Philadelphia chromosome. It typically occurs in the chronic phase and may require treatment with tyrosine kinase inhibitors.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
